NASDAQ · Financial Statements
Generation Bio Co. (GBIO) Financial Statements
$5.34
NASDAQ: GBIO
Market Cap $35.98M
Overview Financials Dividend Generation Bio Co. most recently reported annual revenue of $20.0M, net profit of $-132.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024 Revenue $0 $0 $0 $6.0M $20.0M Operating Profit $-81.0M $-119.0M $-141.0M $-139.0M $-142.0M Net Profit $-81.0M $-119.0M $-137.0M $-127.0M $-132.0M EPS $-29.54 $-21.17 $-23.51 $-19.63 $-19.76 Op Margin — — — -2346.9% -715.8%
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024 Total Assets $294.0M $477.0M $376.0M $375.0M $231.0M Total Liabilities $26.0M $95.0M $94.0M $172.0M $145.0M Cash $63.0M $375.0M $93.0M $66.0M $76.0M Borrowings $0 $81.0M $82.0M $98.0M $94.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024 Operating Cash Flow $-70.0M $-92.0M $-102.0M $-53.0M $-89.0M Investing Cash Flow $-211.0M $187.0M $-201.0M $-17.0M $92.0M Financing Cash Flow $0 $3.0M $-1.0M $0 $0 Net Cash Flow $48.0M $316.0M $-282.0M $-27.0M $6.0M Free Cash Flow $-76.0M $-98.0M $-111.0M $-60.0M $-91.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -1.01 FCF Yield -273.94% Quick Ratio 4.44 Interest Coverage 0.00 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock